Article Figures & Data
Figures
- Fig. 1.
Chemical structures and m/z values of ginsenosides and their main degradation products in addition to their major fragment ions observed in the first fragmentation step (MS2).
Glc, β-d-glucopyranosyl; Arap, α-l-arabinopyranosyl; Arafp, α-l-arabinofuranosyl; Rha, α-l-rhamnopyranosyl. *, the degradation products of ginsenosides detected in this study.
- Fig. 2.
ESI-MS spectrum showing the ginsenosides present in Ginsana.
The signal intensity does not reflect the relative abundance of the extract constituent.
- Fig. 3.
Ginsenosides and their degradation products identified in plasma and urine.
- Fig. 4.
Identification of G-Rb1in subject's plasma on the basis of its specific fragment ions at m/z 789 and m/z 365 (a); and identification of C-K in subject's urine by means of its characteristic fragment ion at m/z 203 (b).
- Fig. 5.
Possible degradation pathway of G-Rg1and G-Re under different conditions.
